All-Cause Mortality Associated With Atypical and Conventional Antipsychotics Among Nursing Home Residents With Dementia
- 15 October 2009
- journal article
- research article
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 70 (10), 1340-1347
- https://doi.org/10.4088/jcp.08m04597yel
Abstract
A recent meta-analysis has indicated that, in patients with dementia, the use of atypical antipsychotics is associated with an excess mortality. Later observational studies have suggested that conventional antipsychotics may pose an even greater risk of death. None of these studies could evaluate the risk associated with single antipsychotics nor could they provide any conclusive evidence concerning the risk among nursing home residents. We conducted a retrospective cohort study to compare the risk of death associated with atypical and conventional antipsychotics in a large population of nursing home residents with dementia. We identified 6,524 new users of atypical antipsychotics and 3,205 new users of conventional antipsychotics living in 1,581 Medicare- or Medicaid-certified nursing homes in 5 US states during the years 1998–2000. The outcome measure was all-cause mortality, which was determined during 6-months of follow-up. After adjusting for potential confounders relative to users of atypicals, the rate of death was increased for users of conventional antipsychotics (hazard ratio [HR], 1.26; 95% CI, 1.13–1.42). Relative to risperidone, a higher rate of death was documented for haloperidol (HR, 1.31; 95% CI, 1.13–1.53), phenothiazines (HR, 1.17; 95% CI, 1.00–1.38) and other conventional medications (HR, 1.32; 95% CI, 0.99–1.80). No atypical antipsychotic was associated with a differential risk relative to risperidone. Conventional antipsychotics are associated with a higher risk of all-cause mortality than atypical agents. It seems advisable that they are not used in substitution for atypical antipsychotics among nursing home residents with dementia even when short-term therapy is being prescribed.Keywords
This publication has 38 references indexed in Scilit:
- Use of antipsychotics in elderly patients with dementia: Do atypical and conventional agents have a similar safety profile?Pharmacological Research, 2009
- Lower Mortality in Geriatric Patients Receiving Risperidone and Olanzapine Versus Haloperidol: Preliminary Analysis of Retrospective DataAmerican Journal of Geriatric Psychiatry, 2004
- Atypical Antipsychotics and Risk of Cerebrovascular AccidentsAmerican Journal of Psychiatry, 2004
- A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.2004
- Consensus Statement on Improving the Quality of Mental Health Care in U.S. Nursing Homes: Management of Depression and Behavioral Symptoms Associated with DementiaJournal of the American Geriatrics Society, 2003
- Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative dataBMJ, 2002
- Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County studyInternational Journal of Geriatric Psychiatry, 2001
- Conventional and Atypical Antipsychotics and the Evolving Standard of CarePsychiatric Services, 2000
- Scaling ADLs Within the MDSThe Journals of Gerontology: Series A, 1999
- The MDS Cognition Scale: A Valid Instrument for Identifying and Staging Nursing Home Residents with Dementia Using the Minimum Data SetJournal of the American Geriatrics Society, 1994